Fundraising FoxAerion Bioscience
1 known investors
Find your way into Aerion Bioscience
Sign up to see every warm intro you have to Aerion Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aerion Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer. The company is conducting clinical testing to validate the panel's ability to detect lung cancer, distinguish its stages and aggressiveness, and identify other lung conditions.
Founders & leadership
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Aerion Bioscience do?
- Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer. The company is conducting clinical testing to validate the panel's ability to detect lung cancer, distinguish its stages and aggressiveness, and identify other lung conditions.
- Who are Aerion Bioscience's investors?
- Aerion Bioscience's investors include NLC.